NDC 25021-654

NDC 25021-654

NDC 25021-654 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 25021-654
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 25021-654-20 [25021065420]

Ropivacaine Hydrochloride INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA090318
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2014-09-23
Marketing End Date2017-08-31

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.